cbdMD (NYSEAMERICAN:YCBD) Shares Down 0.1% – Here’s Why

cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Free Report) was down 0.1% on Friday . The stock traded as low as $0.56 and last traded at $0.5650. 105,812 shares traded hands during trading, a decline of 57% from the average session volume of 245,720 shares. The stock had previously closed at $0.5657.

cbdMD Stock Down 0.1%

The company has a 50 day moving average price of $0.65 and a 200-day moving average price of $0.75.

Get cbdMD alerts:

cbdMD (NYSEAMERICAN:YCBD – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The business had revenue of $5.64 million for the quarter, compared to the consensus estimate of $5.29 million. cbdMD had a negative return on equity of 33.60% and a negative net margin of 13.29%.

Institutional Investors Weigh In On cbdMD

A hedge fund recently bought a new position in cbdMD stock. Jane Street Group LLC acquired a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned approximately 0.49% of cbdMD at the end of the most recent reporting period. 7.18% of the stock is currently owned by institutional investors.

cbdMD Company Profile

(Get Free Report)

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.

See Also

• Five stocks we like better than cbdMD
• 3 Stocks Whose Charts May Be Signaling the Next Big Move
• Quantum Earnings Week: Winners and Losers Are Finally Emerging
• Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
• Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.